Condition: Acute Gout Flare · Gout Attack · Gout Flare · Sponsor: Olatec Therapeutics, Inc.
The purpose of this trial is to investigate the efficacy and safety of dapansutrile (OLT1177®) tablets in subjects with an acute gout flare.
This description comes directly from the study's public registry record.
Philip Piscitelli · +1 833-652-8321 · phil.piscitelli@olatec.com
Clinical Operations · clinops@olatec.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Withdrawn |
| Arizona Arthritis & Rheumatology Associates - Glendale | Glendale, Arizona, United States | Recruiting |
| Arizona Arthritis & Rheumatology Associates (AARA), P.C. - Mesa | Mesa, Arizona, United States | Recruiting |
| American Institute of Research | Los Angeles, California, United States | Withdrawn |
| TriWest Research Associates | San Diego, California, United States | Recruiting |
| Valiance Clinical Research - Tarzana | Tarzana, California, United States | Recruiting |
| Hillcrest Medical Research | DeLand, Florida, United States | Recruiting |
| SIMEDHealth | Gainesville, Florida, United States | Recruiting |
| University of Florida Health Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Well Pharma Medical Research | Miami, Florida, United States | Recruiting |
| Clinical Research of West Florida | Tampa, Florida, United States | Recruiting |
| Arthritis Center of North Georgia - Gainesville | Gainesville, Georgia, United States | Recruiting |
+ 28 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05658575